CFTR and cystic fibrosis-related liver disease: Further possibilities evolve by the use of clustered regulatory interspaced short palindrome repeats (CRISPR)/Cas9 to repair defective CFTR in vitro and in vivo [67,68,69], but have not been tested in models of CFLD or humans so far.